当前位置: X-MOL 学术Journal of Legal Medicine › 论文详情
Ten Years of FDA Tobacco Regulation: Lessons for Public Health Stakeholders
Journal of Legal Medicine ( IF 0.417 ) Pub Date : 2021-04-02 , DOI: 10.1080/01947648.2020.1868940
Desmond Jenson

Abstract

In the 10 years that the U.S. Food and Drug Administration (FDA) has been regulating tobacco products, the agency has been plagued with setbacks, some of its own making, and some the result of outside forces. What has been consistently true is that the public health community has not had as much of a voice as it should have until public health groups began filing lawsuits against the FDA. This article examines four areas of FDA regulation over the last decade in an attempt to qualitatively describe the work of the Center for Tobacco Products and identify opportunities for public health groups to have greater advocacy success in the future.



中文翻译:

FDA烟草监管十年:公共卫生利益相关者的经验教训

摘要

在美国食品药品监督管理局(FDA)监管烟草产品的10年中,该机构一直遭受挫折,一些自己制造的产品以及一些外来因素的影响。一直以来的真实情况是,在公共卫生组织开始对FDA提起诉讼之前,公共卫生界没有应有的发言权。本文研究了过去十年来FDA监管的四个领域,以定性地描述烟草产品中心的工作,并确定公共卫生团体在未来获得更大宣传成功的机会。

更新日期:2021-04-02
全部期刊列表>>
2021中国学者有奖调研
JACS
材料科学跨学科高质量前沿研究
中国作者高影响力研究精选
虚拟特刊
屿渡论文,编辑服务
何川
清华大学
郭维
上海中医药大学
华东师范大学
北京大学许言
楚甲祥
西湖石航
上海交大
北理工
隐藏1h前已浏览文章
课题组网站
新版X-MOL期刊搜索和高级搜索功能介绍
ACS材料视界
南开大学
张韶光
华辉
天合科研
x-mol收录
试剂库存
down
wechat
bug